MBBS · Pharmacology

Unit 6: Endocrine Pharmacology MCQs

45 solved multiple choice questions with answers and short explanations.

Q1. Which mechanism best explains the principal pharmacologic action of Regular insulin?

  1. Aactivates insulin receptor tyrosine kinase signaling
  2. Breduces hepatic gluconeogenesis and improves insulin sensitivity
  3. Cenhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying
  4. Dreplaces synthetic thyroxine T4
Show answer
Answer: A. activates insulin receptor tyrosine kinase signalingRegular insulin activates insulin receptor tyrosine kinase signaling. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q2. Which clinical use is most appropriately associated with Regular insulin?

  1. Atype 2 diabetes with residual beta-cell function
  2. Bcontrol of hyperglycemia including intravenous use in diabetic ketoacidosis
  3. Ctype 2 diabetes, heart failure, and chronic kidney disease in selected patients
  4. Dselected hyperthyroid states including thyroid storm
Show answer
Answer: B. control of hyperglycemia including intravenous use in diabetic ketoacidosisRegular insulin is used for control of hyperglycemia including intravenous use in diabetic ketoacidosis. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q3. Which adverse effect or toxicity is particularly important to recognize with Regular insulin?

  1. Agenital mycotic infections and euglycemic ketoacidosis
  2. BGI upset and rare lactic acidosis
  3. Chypoglycemia and weight gain
  4. Dagranulocytosis and hepatotoxicity
Show answer
Answer: C. hypoglycemia and weight gainAn important safety issue with Regular insulin is hypoglycemia and weight gain. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q4. A drug activates insulin receptor tyrosine kinase signaling and is used for control of hyperglycemia including intravenous use in diabetic ketoacidosis. Which drug best matches this description?

  1. APrednisone
  2. BMetformin
  3. CLevothyroxine
  4. DRegular insulin
Show answer
Answer: D. Regular insulinThe description matches Regular insulin: it activates insulin receptor tyrosine kinase signaling and is used for control of hyperglycemia including intravenous use in diabetic ketoacidosis.
Report a mistake

Q5. Which mechanism best explains the principal pharmacologic action of Metformin?

  1. Areduces hepatic gluconeogenesis and improves insulin sensitivity
  2. Bclose ATP-sensitive potassium channels in pancreatic beta cells
  3. Cblock renal proximal-tubule glucose reabsorption
  4. Dinhibits thyroid peroxidase-mediated hormone synthesis
Show answer
Answer: A. reduces hepatic gluconeogenesis and improves insulin sensitivityMetformin reduces hepatic gluconeogenesis and improves insulin sensitivity. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q6. Which clinical use is most appropriately associated with Metformin?

  1. Atype 2 diabetes and, for some agents, obesity management
  2. Bfirst-line therapy for many patients with type 2 diabetes
  3. Chypothyroidism
  4. Dinflammatory and autoimmune disorders
Show answer
Answer: B. first-line therapy for many patients with type 2 diabetesMetformin is used for first-line therapy for many patients with type 2 diabetes. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q7. Which adverse effect or toxicity is particularly important to recognize with Metformin?

  1. Aexcess dosing can cause symptoms of thyrotoxicosis
  2. Bhypoglycemia and weight gain
  3. CGI upset and rare lactic acidosis
  4. Dsevere hepatotoxicity and agranulocytosis
Show answer
Answer: C. GI upset and rare lactic acidosisAn important safety issue with Metformin is GI upset and rare lactic acidosis. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q8. A drug reduces hepatic gluconeogenesis and improves insulin sensitivity and is used for first-line therapy for many patients with type 2 diabetes. Which drug best matches this description?

  1. AFludrocortisone
  2. BSulfonylureas
  3. CMethimazole
  4. DMetformin
Show answer
Answer: D. MetforminThe description matches Metformin: it reduces hepatic gluconeogenesis and improves insulin sensitivity and is used for first-line therapy for many patients with type 2 diabetes.
Report a mistake

Q9. Which mechanism best explains the principal pharmacologic action of Sulfonylureas?

  1. Aclose ATP-sensitive potassium channels in pancreatic beta cells
  2. Benhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying
  3. Creplaces synthetic thyroxine T4
  4. Dinhibits thyroid peroxidase and peripheral T4-to-T3 conversion
Show answer
Answer: A. close ATP-sensitive potassium channels in pancreatic beta cellsSulfonylureas close ATP-sensitive potassium channels in pancreatic beta cells. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q10. Which clinical use is most appropriately associated with Sulfonylureas?

  1. Atype 2 diabetes, heart failure, and chronic kidney disease in selected patients
  2. Btype 2 diabetes with residual beta-cell function
  3. Chyperthyroidism
  4. Dmineralocorticoid replacement
Show answer
Answer: B. type 2 diabetes with residual beta-cell functionSulfonylureas is used for type 2 diabetes with residual beta-cell function. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q11. Which adverse effect or toxicity is particularly important to recognize with Sulfonylureas?

  1. Aagranulocytosis and hepatotoxicity
  2. BGI adverse effects and gallbladder-related events
  3. Chypoglycemia and weight gain
  4. Dhyperglycemia, osteoporosis, infection risk, and adrenal suppression
Show answer
Answer: C. hypoglycemia and weight gainAn important safety issue with Sulfonylureas is hypoglycemia and weight gain. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q12. A drug close ATP-sensitive potassium channels in pancreatic beta cells and is used for type 2 diabetes with residual beta-cell function. Which drug best matches this description?

  1. ACombined oral contraceptives
  2. BGLP-1 receptor agonists
  3. CPropylthiouracil
  4. DSulfonylureas
Show answer
Answer: D. SulfonylureasThe description matches Sulfonylureas: it close ATP-sensitive potassium channels in pancreatic beta cells and is used for type 2 diabetes with residual beta-cell function.
Report a mistake

Q13. Which mechanism best explains the principal pharmacologic action of GLP-1 receptor agonists?

  1. Aenhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying
  2. Bblock renal proximal-tubule glucose reabsorption
  3. Cinhibits thyroid peroxidase-mediated hormone synthesis
  4. Dactivates intracellular glucocorticoid receptors after conversion to prednisolone
Show answer
Answer: A. enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptyingGLP-1 receptor agonists enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q14. Which clinical use is most appropriately associated with GLP-1 receptor agonists?

  1. Ahypothyroidism
  2. Btype 2 diabetes and, for some agents, obesity management
  3. Cselected hyperthyroid states including thyroid storm
  4. Dcontraception and selected menstrual disorders
Show answer
Answer: B. type 2 diabetes and, for some agents, obesity managementGLP-1 receptor agonists is used for type 2 diabetes and, for some agents, obesity management. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q15. Which adverse effect or toxicity is particularly important to recognize with GLP-1 receptor agonists?

  1. Asevere hepatotoxicity and agranulocytosis
  2. Bgenital mycotic infections and euglycemic ketoacidosis
  3. CGI adverse effects and gallbladder-related events
  4. Dhypertension, edema, and hypokalemia
Show answer
Answer: C. GI adverse effects and gallbladder-related eventsAn important safety issue with GLP-1 receptor agonists is GI adverse effects and gallbladder-related events. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q16. A drug enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying and is used for type 2 diabetes and, for some agents, obesity management. Which drug best matches this description?

  1. ATamoxifen
  2. BSGLT2 inhibitors
  3. CPrednisone
  4. DGLP-1 receptor agonists
Show answer
Answer: D. GLP-1 receptor agonistsThe description matches GLP-1 receptor agonists: it enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying and is used for type 2 diabetes and, for some agents, obesity management.
Report a mistake

Q17. Which mechanism best explains the principal pharmacologic action of SGLT2 inhibitors?

  1. Ablock renal proximal-tubule glucose reabsorption
  2. Breplaces synthetic thyroxine T4
  3. Cinhibits thyroid peroxidase and peripheral T4-to-T3 conversion
  4. Dactivates mineralocorticoid receptors
Show answer
Answer: A. block renal proximal-tubule glucose reabsorptionSGLT2 inhibitors block renal proximal-tubule glucose reabsorption. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q18. Which clinical use is most appropriately associated with SGLT2 inhibitors?

  1. Ahyperthyroidism
  2. Btype 2 diabetes, heart failure, and chronic kidney disease in selected patients
  3. Cinflammatory and autoimmune disorders
  4. Destrogen-receptor-positive breast cancer
Show answer
Answer: B. type 2 diabetes, heart failure, and chronic kidney disease in selected patientsSGLT2 inhibitors is used for type 2 diabetes, heart failure, and chronic kidney disease in selected patients. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q19. Which adverse effect or toxicity is particularly important to recognize with SGLT2 inhibitors?

  1. Ahyperglycemia, osteoporosis, infection risk, and adrenal suppression
  2. Bexcess dosing can cause symptoms of thyrotoxicosis
  3. Cgenital mycotic infections and euglycemic ketoacidosis
  4. Dvenous thromboembolism risk and hypertension
Show answer
Answer: C. genital mycotic infections and euglycemic ketoacidosisAn important safety issue with SGLT2 inhibitors is genital mycotic infections and euglycemic ketoacidosis. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q20. A drug block renal proximal-tubule glucose reabsorption and is used for type 2 diabetes, heart failure, and chronic kidney disease in selected patients. Which drug best matches this description?

  1. AAnastrozole
  2. BLevothyroxine
  3. CFludrocortisone
  4. DSGLT2 inhibitors
Show answer
Answer: D. SGLT2 inhibitorsThe description matches SGLT2 inhibitors: it block renal proximal-tubule glucose reabsorption and is used for type 2 diabetes, heart failure, and chronic kidney disease in selected patients.
Report a mistake

Q21. Which mechanism best explains the principal pharmacologic action of Levothyroxine?

  1. Areplaces synthetic thyroxine T4
  2. Binhibits thyroid peroxidase-mediated hormone synthesis
  3. Cactivates intracellular glucocorticoid receptors after conversion to prednisolone
  4. Dsuppress ovulation through estrogen-progestin feedback on gonadotropins
Show answer
Answer: A. replaces synthetic thyroxine T4Levothyroxine replaces synthetic thyroxine T4. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q22. Which clinical use is most appropriately associated with Levothyroxine?

  1. Aselected hyperthyroid states including thyroid storm
  2. Bhypothyroidism
  3. Cmineralocorticoid replacement
  4. Dpostmenopausal estrogen-receptor-positive breast cancer
Show answer
Answer: B. hypothyroidismLevothyroxine is used for hypothyroidism. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q23. Which adverse effect or toxicity is particularly important to recognize with Levothyroxine?

  1. Ahypertension, edema, and hypokalemia
  2. Bagranulocytosis and hepatotoxicity
  3. Cexcess dosing can cause symptoms of thyrotoxicosis
  4. Dvenous thromboembolism and endometrial cancer risk
Show answer
Answer: C. excess dosing can cause symptoms of thyrotoxicosisAn important safety issue with Levothyroxine is excess dosing can cause symptoms of thyrotoxicosis. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q24. A drug replaces synthetic thyroxine T4 and is used for hypothyroidism. Which drug best matches this description?

  1. AAlendronate
  2. BMethimazole
  3. CCombined oral contraceptives
  4. DLevothyroxine
Show answer
Answer: D. LevothyroxineThe description matches Levothyroxine: it replaces synthetic thyroxine T4 and is used for hypothyroidism.
Report a mistake

Q25. Which mechanism best explains the principal pharmacologic action of Methimazole?

  1. Ainhibits thyroid peroxidase-mediated hormone synthesis
  2. Binhibits thyroid peroxidase and peripheral T4-to-T3 conversion
  3. Cactivates mineralocorticoid receptors
  4. Dselectively modulates estrogen receptors, antagonizing estrogen in breast tissue
Show answer
Answer: A. inhibits thyroid peroxidase-mediated hormone synthesisMethimazole inhibits thyroid peroxidase-mediated hormone synthesis. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q26. Which clinical use is most appropriately associated with Methimazole?

  1. Ainflammatory and autoimmune disorders
  2. Bhyperthyroidism
  3. Ccontraception and selected menstrual disorders
  4. Dosteoporosis
Show answer
Answer: B. hyperthyroidismMethimazole is used for hyperthyroidism. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q27. Which adverse effect or toxicity is particularly important to recognize with Methimazole?

  1. Avenous thromboembolism risk and hypertension
  2. Bsevere hepatotoxicity and agranulocytosis
  3. Cagranulocytosis and hepatotoxicity
  4. Dbone loss and arthralgia
Show answer
Answer: C. agranulocytosis and hepatotoxicityAn important safety issue with Methimazole is agranulocytosis and hepatotoxicity. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q28. A drug inhibits thyroid peroxidase-mediated hormone synthesis and is used for hyperthyroidism. Which drug best matches this description?

  1. ATeriparatide
  2. BPropylthiouracil
  3. CTamoxifen
  4. DMethimazole
Show answer
Answer: D. MethimazoleThe description matches Methimazole: it inhibits thyroid peroxidase-mediated hormone synthesis and is used for hyperthyroidism.
Report a mistake

Q29. Which mechanism best explains the principal pharmacologic action of Propylthiouracil?

  1. Ainhibits thyroid peroxidase and peripheral T4-to-T3 conversion
  2. Bactivates intracellular glucocorticoid receptors after conversion to prednisolone
  3. Csuppress ovulation through estrogen-progestin feedback on gonadotropins
  4. Dinhibits aromatase
Show answer
Answer: A. inhibits thyroid peroxidase and peripheral T4-to-T3 conversionPropylthiouracil inhibits thyroid peroxidase and peripheral T4-to-T3 conversion. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q30. Which clinical use is most appropriately associated with Propylthiouracil?

  1. Amineralocorticoid replacement
  2. Bselected hyperthyroid states including thyroid storm
  3. Cestrogen-receptor-positive breast cancer
  4. Dselected patients with severe osteoporosis
Show answer
Answer: B. selected hyperthyroid states including thyroid stormPropylthiouracil is used for selected hyperthyroid states including thyroid storm. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q31. Which adverse effect or toxicity is particularly important to recognize with Propylthiouracil?

  1. Avenous thromboembolism and endometrial cancer risk
  2. Bhyperglycemia, osteoporosis, infection risk, and adrenal suppression
  3. Csevere hepatotoxicity and agranulocytosis
  4. Desophagitis and rare osteonecrosis of the jaw
Show answer
Answer: C. severe hepatotoxicity and agranulocytosisAn important safety issue with Propylthiouracil is severe hepatotoxicity and agranulocytosis. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q32. A drug inhibits thyroid peroxidase and peripheral T4-to-T3 conversion and is used for selected hyperthyroid states including thyroid storm. Which drug best matches this description?

  1. ARegular insulin
  2. BPrednisone
  3. CAnastrozole
  4. DPropylthiouracil
Show answer
Answer: D. PropylthiouracilThe description matches Propylthiouracil: it inhibits thyroid peroxidase and peripheral T4-to-T3 conversion and is used for selected hyperthyroid states including thyroid storm.
Report a mistake

Q33. Which mechanism best explains the principal pharmacologic action of Prednisone?

  1. Aactivates intracellular glucocorticoid receptors after conversion to prednisolone
  2. Bactivates mineralocorticoid receptors
  3. Cselectively modulates estrogen receptors, antagonizing estrogen in breast tissue
  4. Dinhibits osteoclast-mediated bone resorption
Show answer
Answer: A. activates intracellular glucocorticoid receptors after conversion to prednisolonePrednisone activates intracellular glucocorticoid receptors after conversion to prednisolone. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q34. Which clinical use is most appropriately associated with Prednisone?

  1. Acontraception and selected menstrual disorders
  2. Binflammatory and autoimmune disorders
  3. Cpostmenopausal estrogen-receptor-positive breast cancer
  4. Dcontrol of hyperglycemia including intravenous use in diabetic ketoacidosis
Show answer
Answer: B. inflammatory and autoimmune disordersPrednisone is used for inflammatory and autoimmune disorders. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q35. Which adverse effect or toxicity is particularly important to recognize with Prednisone?

  1. Abone loss and arthralgia
  2. Bhypertension, edema, and hypokalemia
  3. Chyperglycemia, osteoporosis, infection risk, and adrenal suppression
  4. Dhypercalcemia and treatment-duration limitations
Show answer
Answer: C. hyperglycemia, osteoporosis, infection risk, and adrenal suppressionAn important safety issue with Prednisone is hyperglycemia, osteoporosis, infection risk, and adrenal suppression. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q36. A drug activates intracellular glucocorticoid receptors after conversion to prednisolone and is used for inflammatory and autoimmune disorders. Which drug best matches this description?

  1. AMetformin
  2. BFludrocortisone
  3. CAlendronate
  4. DPrednisone
Show answer
Answer: D. PrednisoneThe description matches Prednisone: it activates intracellular glucocorticoid receptors after conversion to prednisolone and is used for inflammatory and autoimmune disorders.
Report a mistake

Q37. Which mechanism best explains the principal pharmacologic action of Fludrocortisone?

  1. Aactivates mineralocorticoid receptors
  2. Bsuppress ovulation through estrogen-progestin feedback on gonadotropins
  3. Cinhibits aromatase
  4. Dacts as a parathyroid hormone receptor agonist when given intermittently
Show answer
Answer: A. activates mineralocorticoid receptorsFludrocortisone activates mineralocorticoid receptors. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q38. Which clinical use is most appropriately associated with Fludrocortisone?

  1. Aestrogen-receptor-positive breast cancer
  2. Bmineralocorticoid replacement
  3. Costeoporosis
  4. Dfirst-line therapy for many patients with type 2 diabetes
Show answer
Answer: B. mineralocorticoid replacementFludrocortisone is used for mineralocorticoid replacement. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q39. Which adverse effect or toxicity is particularly important to recognize with Fludrocortisone?

  1. Aesophagitis and rare osteonecrosis of the jaw
  2. Bvenous thromboembolism risk and hypertension
  3. Chypertension, edema, and hypokalemia
  4. Dhypoglycemia and weight gain
Show answer
Answer: C. hypertension, edema, and hypokalemiaAn important safety issue with Fludrocortisone is hypertension, edema, and hypokalemia. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q40. A drug activates mineralocorticoid receptors and is used for mineralocorticoid replacement. Which drug best matches this description?

  1. ASulfonylureas
  2. BCombined oral contraceptives
  3. CTeriparatide
  4. DFludrocortisone
Show answer
Answer: D. FludrocortisoneThe description matches Fludrocortisone: it activates mineralocorticoid receptors and is used for mineralocorticoid replacement.
Report a mistake

Q41. Which mechanism best explains the principal pharmacologic action of Combined oral contraceptives?

  1. Asuppress ovulation through estrogen-progestin feedback on gonadotropins
  2. Bselectively modulates estrogen receptors, antagonizing estrogen in breast tissue
  3. Cinhibits osteoclast-mediated bone resorption
  4. Dactivates insulin receptor tyrosine kinase signaling
Show answer
Answer: A. suppress ovulation through estrogen-progestin feedback on gonadotropinsCombined oral contraceptives suppress ovulation through estrogen-progestin feedback on gonadotropins. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q42. Which clinical use is most appropriately associated with Combined oral contraceptives?

  1. Apostmenopausal estrogen-receptor-positive breast cancer
  2. Bcontraception and selected menstrual disorders
  3. Cselected patients with severe osteoporosis
  4. Dtype 2 diabetes with residual beta-cell function
Show answer
Answer: B. contraception and selected menstrual disordersCombined oral contraceptives is used for contraception and selected menstrual disorders. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q43. Which adverse effect or toxicity is particularly important to recognize with Combined oral contraceptives?

  1. Ahypercalcemia and treatment-duration limitations
  2. Bvenous thromboembolism and endometrial cancer risk
  3. Cvenous thromboembolism risk and hypertension
  4. DGI upset and rare lactic acidosis
Show answer
Answer: C. venous thromboembolism risk and hypertensionAn important safety issue with Combined oral contraceptives is venous thromboembolism risk and hypertension. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q44. A drug suppress ovulation through estrogen-progestin feedback on gonadotropins and is used for contraception and selected menstrual disorders. Which drug best matches this description?

  1. AGLP-1 receptor agonists
  2. BTamoxifen
  3. CRegular insulin
  4. DCombined oral contraceptives
Show answer
Answer: D. Combined oral contraceptivesThe description matches Combined oral contraceptives: it suppress ovulation through estrogen-progestin feedback on gonadotropins and is used for contraception and selected menstrual disorders.
Report a mistake

Q45. Which mechanism best explains the principal pharmacologic action of Tamoxifen?

  1. Aselectively modulates estrogen receptors, antagonizing estrogen in breast tissue
  2. Binhibits aromatase
  3. Cacts as a parathyroid hormone receptor agonist when given intermittently
  4. Dreduces hepatic gluconeogenesis and improves insulin sensitivity
Show answer
Answer: A. selectively modulates estrogen receptors, antagonizing estrogen in breast tissueTamoxifen selectively modulates estrogen receptors, antagonizing estrogen in breast tissue. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake